SPA
RMD icon

Sherbrooke Park Advisers’s ResMed RMD Stock Holding History

Sherbrooke Park Advisers’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,959
Closed -$536K – 476
2025
Q3 		$536K Buy
+1,959
New +$535K 0.25% 148
2025
Q1 		– Sell
-2,363
Closed -$540K – 883
2024
Q4 		$540K Buy
+2,363
New +$569K 0.17% 188
2023
Q4 		– Sell
-8,236
Closed -$1.22M – 644
2023
Q3 		$1.22M Buy
+8,236
New +$1.49M 0.39% 62
2023
Q1 		– Sell
-1,100
Closed -$229K – 302
2022
Q4 		$229K Buy
+1,100
New +$242K 0.17% 230

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Sherbrooke Park Advisers's RMD Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of ResMed (RMD) in Q4 2025, closing a stake of 1,959 shares — an estimated $536K sold.

Sherbrooke Park Advisers first reported a position in RMD in Q4 2022 and held it in 4 quarters. The position peaked at $1.22M in Q3 2023. 946 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 1,959 ResMed shares in Q4 2025, an estimated $536K.
  • Sherbrooke Park Advisers first reported a position in ResMed in Q4 2022 and held it in 4 quarters.
  • Sherbrooke Park Advisers's ResMed position peaked at $1.22M in Q3 2023.
  • 946 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.